Allergan Hit With $212M Verdict In Botox Suit

Law360, New York (April 28, 2011, 9:20 PM EDT) -- Allergan Inc. on Thursday was ordered by a federal jury in Virginia to pay $212 million to a man who suffered brain damage after treating a tremor and cramp in his right hand with the company's Botox drug.

The jury awarded Douglas M. Ray Jr. $200 million in punitive damages and $12 million to compensate him for injuries, a decision following Allergan's $600 million September settlement with the U.S. Department of Justice over its off-label marketing of Botox.

Ray Chester of McGinnis Lochridge & Kilgore LLP,...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Ray v. Allergan, Inc. et al


Case Number

3:10-cv-00136

Court

Virginia Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Robert E. Payne

Date Filed

March 2, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.